Clinical Trials Browser

Phase 2 × NIH × glofitamab × Clear all

NCT07003295 2026-03-19

Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy

Phase 2 Recruiting

Lymphoma, Mantle-Cell